Global Biobanking Market Worth $5.0 billion by 2028
The Global Biobanking Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594
Biobanking Market Dynamics
DRIVER: Growing investments and funding for biobanks
Biobanks have gained significant...
Exploring the Booming Biobanking Market: Opportunities and Challenges
The biobanking industry is expected to witness significant growth and transformation in the near future. Biobanks play a crucial role in collecting, storing, and managing biological samples and associated data for research and healthcare purposes. With the advancements in precision medicine, personalized therapies, and genomic research, the demand for high-quality biological specimens for biomedical...
The Global Biobanking Market: Trends, Growth, and Future Scope
Biobanking Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood...
Research Insights on Biobanking Market Share, Size and Analysis Report
MarketsAndMarkets published a research report on Biobanking Market. The Research Report contains an in-depth study providing a complete analysis of the industry and Future Forecast. The Biobanking Industry research report lists the leading competitors and provides the key factors influencing the market growth. Considering all the major industry trends, market dynamics and competitive scenario.
The...
Global Biobanking Market by Product is Expected to be More than $2 billion, at CAGR of Nearly 7.8%, Says MarketsAndMarkets
The Biobanking Market by Product is expected to reach $ 2.69 Billion, at a CAGR of 7.8%.
Factors driving the growth of this market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing...